CRISPR Cas9 explained. CRISPR (clustered regularly interspaced short palindromic repeats) are segments of prokaryotic DNA containing short repetitions of base sequences. is an RNA-guided gene-editing platform that makes use of a bacterially derived protein (Cas9) and a synthetic guide RNA to introduce a double strand break at a specific location within the genome.
Cas9 is an enzyme that snips DNA, and CRISPR is a collection of DNA sequences that tells Cas9 exactly where to snip.
- « first View: Taxonomy term
- ‹ previous View: Taxonomy term
- …
- 3 of 11 View: Taxonomy term
- 4 of 11 View: Taxonomy term
- 5 of 11 View: Taxonomy term
- 6 of 11 View: Taxonomy term
- 7 of 11 View: Taxonomy term
- 8 of 11 View: Taxonomy term
- 9 of 11 View: Taxonomy term
- 10 of 11 View: Taxonomy term (Current page)
- 11 of 11 View: Taxonomy term
- next › View: Taxonomy term
- last » View: Taxonomy term
The European Patent Office will
Jennifer Doudna, co-inventor of CRISPR Cas9 technology, or the ability to program genes using a special enzyme, 
If the CRISPR gene editing system is to live up to its disease-curing potential,
The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) today ruled that the inventions claimed in the pending U.S. patent application filed by the Doudna/Charpentier research group and the patents and applications filed by the Broad Institute are separately patentable from one another, thereby moving the...
An initiative launched two years ago by UC Berkeley and UC San Francisco to use CRISPR-Cas9 gene editing to develop new disease therapies is expanding into research on the planet’s major crops and poorly understood microbiomes, with plans to invest $125 million in these areas over the next five years.
UC Berkeley scientists have discovered simple CRISPR systems similar to CRISPR-Cas9 — a gene-editing tool that has revolutionized biology — in previously unexplored bacteria that have eluded efforts to grow them in the laboratory.
Berkeley scientists have developed a quicker and more efficient method to alter the genes of mice with CRISPR-Cas9. The work benefited from input from Professor Jennifer Doudna.